About AZI
AZI is a company based in Bunker Hill (United States) founded in 2017 by Gregory W Brooksby and Clyde Jupiter.. AZI has raised $58.33 million across 1 funding round. AZI offers products and services including Medical Isotopes. AZI operates in a competitive market with competitors including ImaginAb, AC Immune, ARTMS, APRINOIA and NorthStar Medical Radioisotopes, among others.
- Headquarter Bunker Hill, United States
- Founders Gregory W Brooksby, Clyde Jupiter
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Arizona Isotopes Science Research Corp.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$58.33 M (USD)
in 1 rounds
-
Latest Funding Round
$58.33 M (USD), Series C
May 16, 2018
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AZI
AZI offers a comprehensive portfolio of products and services, including Medical Isotopes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for developing and producing isotopes in nuclear medicine
Funding Insights of AZI
AZI has successfully raised a total of $58.33M through 1 strategic funding round. The most recent funding activity was a Series C round of $58.33 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $58.3M
-
First Round
First Round
(16 May 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Series C - AZI | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by AZI
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AZI
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Azi Comparisons
Competitors of AZI
AZI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, ARTMS, APRINOIA and NorthStar Medical Radioisotopes, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| domain | founded_year | HQ Location |
Disease-modifying treatments for neurodegenerative diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about AZI
When was AZI founded?
AZI was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is AZI located?
AZI is headquartered in Bunker Hill, United States. It is registered at Bunker Hill, Illinois, United States.
Who is the current CEO of AZI?
Gregory W Brooksby is the current CEO of AZI. They have also founded this company.
Is AZI a funded company?
AZI is a funded company, having raised a total of $58.33M across 1 funding round to date. The company's 1st funding round was a Series C of $58.33M, raised on May 16, 2018.
What does AZI do?
AZI was founded in 2017 and is based in Bunker Hill, United States. Operations focus on the development and production of radiopharmaceuticals within the medical imaging sector. A range of isotopes, including Strontium-82, Germanium-68, Iodine-123, and Actinium-225, is manufactured for diagnostic imaging and therapeutic applications. The portfolio supports clinical uses in nuclear medicine.
What products or services does AZI offer?
AZI offers Medical Isotopes.